@article{a48bc646c8b548e1a01ab252de3a6a95,
title = "Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework",
abstract = "We used the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to evaluate a Stroke Prevention Team's readiness to prevent strokes in children with sickle cell anemia living in northern Nigeria. The NIH sponsored Stroke Prevention Trial in Nigeria included a goal of a sustainable stroke prevention program. The program's 1-year reach for transcranial Doppler screening was 14.7% (4710/32,000) of which 6.0% (281/4710) had abnormal velocities (≥ 200 cm/s). All participants with abnormal transcranial Doppler velocities were started on hydroxyurea (effectiveness). The leaders of all 5 hospitals agreed to adopt the program. After 1 year, program-implementation and maintenance rates were 100%, demonstrating the program's feasibility and short-term sustainability.",
keywords = "Low-resource setting, Nigeria, RE-AIM, Sickle cell, Stroke prevention",
author = "Ghafuri, {Djamila L.} and Abdullahi, {Shehu U.} and Dambatta, {Abdu H.} and Jamil Galadanci and Tabari, {Musa A.} and Halima Bello-Manga and Nura Idris and Hauwa Inuwa and Aliyu Tijjani and Suleiman, {Aisha A.} and Jibir, {Binta W.} and Safiya Gambo and Gambo, {Awwal I.} and Yusuf Khalifa and Lawal Haliru and Sani Abdulrasheed and Zakari, {Mohammed A.} and Greene, {Brittany C.} and Edwin Trevathan and Jordan, {Lori C.} and Aliyu, {Muktar H.} and Baumann, {Ana A.} and DeBaun, {Michael R.}",
note = "Funding Information: Research reported in this publication was supported by the National Institutes of Health Grant #1R01NS094041-01, P50 CA-19-006, NCT 03380351, UL1 TR00234, 5U24HL136790, the Thrasher Foundation, and the generous donation of the Phillips family. The sponsor did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Publisher Copyright: Copyright {\textcopyright} 2021 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY)",
year = "2022",
month = jan,
day = "1",
doi = "10.1097/MPH.0000000000002179",
language = "English",
volume = "44",
pages = "E56--E61",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
number = "1",
}